http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102050931-B1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-54
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001153
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10
filingDate 2014-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2019-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2019-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-102050931-B1
titleOfInvention Tape preparation of wt1 peptide cancer vaccine for transdermal administration
abstract An object of the present invention is to provide a tape agent for cancer vaccine having higher efficacy by selecting a cellular immune induction promoter that is optimal for the WT1 peptide and / or the modified WT1 peptide. The present invention provides a composition comprising (i) a WT1 peptide and / or a modified WT1 peptide; And (ii) a first cellular immune induction promoter, a cancer vaccine tape for transdermal administration for cellular immune induction.
priorityDate 2013-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009046738-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011046832-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008193487-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010037395-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123962303
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467786203
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433555157
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466268569

Total number of triples: 35.